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Abstract
Hypoxia Inducible Factor (HIF) signaling pathway is important for tumor cells with limited oxygen supplies, as it is shown to
be involved in the process of proliferation and angiogenesis. Given its pivotal role in cancer biology, robust assays for
tracking changes in HIF expression are necessary for understanding its regulation in cancer as well as developing therapies
that target HIF signaling. Here we report a novel HIF reporter construct containing tandem repeats of minimum HIF binding
sites upstream of eYFP coding sequence. We show that the reporter construct has an excellent signal to background ratio
and the reporter activity is HIF dependent and directly correlates with HIF protein levels. By utilizing this new construct, we
assayed HIF activity levels in different cancer cell lines cultured in various degrees of hypoxia. This analysis reveals a
surprising cancer cell line specific variation of HIF activity in the same level of hypoxia. We further show that in two cervical
cancer cell lines, ME180 and HeLa, the different HIF activity levels observed correlate with the levels of hsp90, a cofactor that
protects HIF against VHL-independent degradation. This novel HIF reporter construct serves as a tool to rapidly define HIF
activity levels and therefore the therapeutic capacity of potential HIF repressors in individual cancers.
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Introduction
Hypoxia is well known to fundamentally regulate many aspects of
cell biology. Most of the effects of hypoxia involve the hypoxia
inducible factor (HIF), a highly conserved and crucial oxygen
regulated heterodimeric transcription factor composed of an alpha
(a) and a beta (b) subunit. Both of these subunits belong to the PER-
ARNT-SIM (PAS) group inbasic-helix-loop-helix (bHLH) family of
transcription factors [1]. Two genes encoding mammalian HIFa
subunits (HIF1a, HIF2a) are well studied: HIF1a is ubiquitously
expressed whereas HIF2a exhibit more restricted tissue distribution
[2]. In normoxia, HIFa undergoes prolyl hydroxylation and binds
to an ubiquitin E3-ligase, the von Hippel-Lindau (VHL) protein,
which leads to polyubiquitination and rapid proteosomal degrada-
tionofHIFa[3,4].Underhypoxia,HIFahydroxylationisinhibited,
resulting in accumulation of HIFa and formation of HIFa-HIFb
heterodimers. The heterodimers further complex with the coacti-
vator p300, and bind to the promoters of HIF target genes to induce
gene expression [5]. In addition to hypoxia, many other pathways
can affect HIF stabilization [6,7]. Cofactors, such as PACF P300/
CBP associated factor [8] and hsp90 [9,10], also help facilitate HIF
stabilization and enhance HIF activities. Hsp90 has shown to
protect HIFa against VHL-independent degradation that can occur
in hypoxia [11].
The well studied HIF target genes include those that are
involved in oxygen delivery and cell proliferation, such as the
vascular endothelial growth factor (VEGF) [12,13] and p21 [14]. In
addition, HIF facilitates adaptation to oxygen deprivation by
regulating genes involved in glucose uptake and metabolism, such
as carbonic anhydrase (CA9) [15], which maintains cellular pHi
homeostasis under hypoxia. It was recently reported that HIF and
its target gene, Oct4, are responsible for hypoxia induced cancer
stem cell phenotype that is thought to drive the progression and
aggressiveness in certain tumors [16]. Given its pivotal role in
angiogenesis and tumor progression, HIF is a therapeutically
attractive target and blocking HIF, especially when combined with
conventional therapies, has shown beneficial effects [17,18].
To examine HIFs’ temporal and spatial expression in tissues,
several direct and indirect reporter systems are developed in order
to track HIF protein expression in vivo. Either full length HIF
cDNA, or a fragment under oxygen-dependent regulation has
been linked to fluorescent protein [19], or firefly luciferase [20]
for constructing HIF-fusion proteins. Alternatively, since HIF
fusion protein studies do not reveal whether HIF complex is
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27460transcriptionally active, promoter based reporters have also been
developed. Typically, 5–8 repeats of the hypoxia response
elements (HREs) (59-GCCCTACGTGCTGTCTCACACAGC-
39) from the 39 enhancer region of human Epo gene, or the HRE
from VEGF (59-CACAGTGCATACGTGGGCTCCAACAG-
GTCCTCT-39) are linked in tandem with a minimal promoter
to drive the expression of a downstream reporter gene [21,22]. It is
worth noting that in these constructs, HRE contains not only the
HIF-1a or HIF2a consensus binding sites (59-CGTG-39 and 59-
TRCGTG-39, respectively), but also Epo or VEGF promoter
specific sequences. Recently Oct4 has shown to be induced by HIF
under hypoxia [16], however, Oct4 promoter only contains three
repeats of CGTG, the actual HIF binding site but not the HRE
sequences observed either in Epo or VEGF promoter.
In order to maximize the specificity and sensitivity of the
reporter construct, a strategy of using the most primitive trans-
cription factor binding site in tandem in a reporter has been
successfully utilized previously in the case of Wnt-pathway analysis
[23,24]. In the present study, we utilized a similar strategy to build
up a promoter based reporter, only incorporating the minimal
HIF1a and HIF2a binding sites together (CGTGTACGTG) in
tandem in the promoter. We show that this new HIF reporter with
HIF binding repeats (HBR) has a good signal to background ratio
and signal dynamics in deoxygenation and reoxygenation. We also
demonstrate that the signal is HIF dependent as revealed by HIF
RNAi studies, and it correlates with the cellular HIF protein level
in different cell lines. By utilizing our new construct, we show that
HIF activity levels vary significantly in different cancer cell lines
cultured in the same degree of hypoxia. We further reveal that in
two cervical cancer cell lines, the differences in HIF activity levels
correlate with the level of the HIF cofactor, Hsp90, which protects
HIF against VHL-independent degradation.
Results
We constructed a lentiviral plasmid, in which the expression of
enhanced yellow florescent protein (eYFP) was under the
regulation of twelve tandem repeats of minimal HIF-binding sites
(CGTGTACGTG), followed by a minimal human thymidine
kinase (TK) promoter (12U-HBR). Also, a 770 bps of b-globin
intron sequences was incorporated between the TK promoter and
eYFP for better transcription of eYFP (Figure 1a, Figure S1). To
assay the construct’s function in vitro, we transduced the virus into
HeLa cells and cultured them in either normoxic (20% O2)o r
hypoxic (2% O2) condition. After 24 hours, we observed that cells
under hypoxia uniformly expressed eYFP (,70% of eYFP
positive), while those under normoxia only gained fluorescence
with greatly reduced intensity (,6% of eYFP positive, Figure 1b
and Figure S2).
To further optimize the signal to background ratio, we reduced
the number of HIF-binding sites, thereby creating HIF-reporters
with 3 tandem binding sites (3U-HBR) or with 6 sites (6U-HBR)
(Figure 1a). When analyzing in HeLa cells, we observed that 6U-
HBR construct achieved a better signal-to-background ratio
than 3U-HBR and 12U-HBR constructs (33.4, 5.8 and 15.1,
respectively. Figure 1c). To compare the specificity and sensitivity
to other hypoxia reporters, we specifically obtained one of the
widely used HIF reporter 5HRE_hCMV_Luc [25]. After transient
transfected 5HRE_hCMV_luc reporter in HeLa cells, we
observed 50–100 fold greater luciferase activity under 2% O2 as
compared to cells growing in 20% O2, which was consistent with
the original finding. In comparison, our HBR_eYFP reporter
shows about 30–40 fold increase in 2% O2, an increase that falls in
a similar scale as seen with 5HRE_hCMV_luc reporter. With the
similarity in signal intensity, however, the two HIF reporter
constructs are not directly comparable, given that they have
distinct backbone sequences, different minimal promoters and
reporter genes, all of which could render them distinct behavior
and dynamics under hypoxia. In this study, 6U-HBR was used for
further optimization and characterization.
We next characterized the dynamics of the construct in the
process of deoxygenation and reoxygenation. When transferred
from normoxia to hypoxia (2%), 6U-HBR-HeLa cells had rapid
response (Figure 2a); however, when transferred from hypoxia
back to normoxia, the fluorescent intensity decreased slowly
(72 hours to reach the basal level; Figure 2b). For a construct with
better ability to timely reflect the turnover of HIF, we modified
eYFP and generated a destabilized version by attaching mouse
ornithine decarboxylase 422–461 domain, a region responsible for
rapid degradation of the protein [26], to the C-terminus of eYFP,
therefore creating the construct of 6U-destabilized-HBR (6UD-
HBR). We observed that 6UD-HBR had a reduced fluorescence
but similar dynamics as seen with 6U-HBR (Figure 2a). When
transferred back to normoxia, the fluorescent signal of 6UD-HBR
cells showed dramatic reduction reaching the lowest level in
10 hours. Based on these observations, 6U-HBR is more sensitive
in detecting changes in the process of deoxygenation while 6UD-
HBR better reflects changes in the process of reoxygenation.
To confirm HIF-dependency of the reporter, we performed
RNAi experiments targeting HIFs under hypoxia. When knocking
down three HIFs (HIF1a, HIF1b and HIF2a), 6U-HBR-HeLa
cells under hypoxia had greatly reduced fluorescence, close to the
level seen under normoxia (Figure 3a–f, approximately equal
numbers of cells observed in a–d). Furthermore, we showed that
over-expression of non-degradable HIF1a or HIF2a alone was
sufficient to activate the expression of the construct (Figure 4a and
4b). To test whether the signal induced by HIFa over-expression
(OE) was directly caused by the canonical activity of HIFa,w e
introduced RNAi against the essential cofactor of HIFa, HIF1b,i n
HIFa OE cells. We showed that when transfected with HIF1b
RNAi, the eYFP intensity induced by HIFa OE was greatly
reduced (Figure 4b–d). It is worth noting that in the RNAi
experiments performed in a high-throughput platform, cells
showed equivalent intensity across wells in the same treatment
group (Figure 4b–d). These experiments demonstrate the applica-
bility and sensitivity of the 6U-HBR construct in a high-
throughput platform. The sensitivity of the construct to both
HIF1a and HIF2a was further confirmed by the results when
knocking down individual HIFa or HIFs with various combina-
tions in HeLa cells (Figure S3). Altogether, we show that the
reporter is directly sensing HIF signaling in the cells.
In mammalian embryogenesis and development, tissues develop
in a microenviroment with various levels of oxygen. It has been
shown that hypoxia, on one hand, is essential for heart formation
[27,28,29] and endochondrial bone formation [30,31,32,33];
however, on the other hand, it impairs adipose tissue development
[34,35] and skin myofibroblast differentiation [36]. Given the
critical role of HIF signaling in hypoxia, one fundamental question
is whether cells gain tissue-specific responses to their low oxygen
environment by differentially regulating HIF pathway. To
determine how cells from different tissue origins respond to
hypoxia in terms of HIF levels and activities, we examined 5 6U-
HBR carcinomas cell lines, namely, 786+VHL from renal cell
adenocarcinoma, A549 from lung carcinoma, ME180 from
epidermoid carcinoma in cervix, U251 from glioma, and HeLa
from cervical adenocarcinoma. Cells were incubated in different
oxygen levels (20%, 5%, 3%, 2%, 1% or 0.3%) for 4 days, and the
average 6U-HBR fluorescence was determined by FACS analysis.
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PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e27460Figure 1. Schematic representation of HIF-HBR reporter construct. 3, 6 or 12 tandem units of HIF binding repeats (3U, 6U or 12U-HBR) and a
TK minimal promoter together regulate the eYFP expression. b–c) Optimization of the number of HIF binding repeats. b) 6U-HBR HeLa cells turn eYFP
on in 2% but not in 20% oxygen. Equal amount of cells (5610
4) were plated in both culture dishes and microscopy and FACS analysis were performed
after 2 days; c) the signal-to-background ratio is represented by FACS analysis. HeLa cells were transduced with HIF-HBR reporter lentiviral particles
for 24 hrs and then grown under normoxia (20% O2) or hypoxia (2% O2) for 48 hours before FACS analysis. Ratios are of geometric means of eYFP
intensity in 2% to 20% oxygen.
doi:10.1371/journal.pone.0027460.g001
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hypoxic conditions due to the fact that they have adapted to
culture conditions; however, we observed that they responded
distinctly, under the same degree of oxygen. For instance, ME180
and HeLa both had little response at 3% of oxygen, however,
when oxygen level was below 3%, ME180 exhibited dramatic
increase of the signal, while HeLa had relatively low increase
(Figure 5). On the other hand, the signal of U251 increased slowly
at 5% and 3% of oxygen, more dramatically in 2% and 1% of
oxygen, and distinctly continued to increase even in 0.3% of
oxygen (Figure 5).
We further verified that 6U-HBR signals in these cell lines
correlated with intracellular HIF protein levels. Since the 1%
oxygen environment exhibited the greatest difference in 6U-HBR
signals among ME180, U251 and HeLa cells, we used this level of
oxygen to assay HIF mRNA and protein. While HIF1a mRNA
levels were similar among these cell lines, HIF2a mRNA levels
varied (Figure S4), which was in accordance with a previous study
[2]. For protein level, we first showed that four hours in hypoxia
induced higher HIF1a protein levels in ME180, U251 and A549
than in HeLa and 786-O+VHL (Figure 6a–b). Since it has been
previously reported that in prolonged hypoxia, HIF1a protein
degrades while HIF2a exhibits minimal change [37], we
hypothesized that not only the total HIF protein levels but also
the stabilization dynamics of the proteins are responsible for
different 6U-HBR reporter activities in these cell lines. We
therefore analyzed the differences in degradation kinetics of HIFa
proteins in all the five cancer cell lines in 1% of oxygen. This
analysis revealed that HIF1a in HeLa cells is less stable during
prolonged hypoxia than in any other cell types analyzed (Figure 6c
Figure 2. Dynamics of 6U-HBR and 6UD-HBR HeLa cell lines. 5610
4 cells were plated onto 35 mm plates and then cultured under either
normoxia (20% O2) or hypoxia (2% O2). At different time points, cells were harvested and fixed for FACS analysis. Mean and error bars are from three
biological repeats.
doi:10.1371/journal.pone.0027460.g002
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normaxia, the difference among these five cell lines is diminished
in terms of total protein levels and degradation patterns (Figure
S5). However, while no HIF1a protein was observed in 786-
O+VHL cells, HIF2a protein was induced in hypoxia in this cell
lines, explaning the responsiveness of this cell line to the 6U-HBR
reporter (Figure S5; Figure 5). Altogether, the data show that
higher levels of more stable HIFa proteins are observed in ME180,
A549 and U251 compared to HeLa and 786-O+VHL cells,
supporting the findings revealed by 6U-HBR reporter that these
five cell lines display distinct HIF activities in the same degree of
hypoxia.
Figure 3. 6U-HBR construct is HIF-dependent. 6U-HBR HeLa cells transfected with siRNAs against three HIFs (HIF1a, HIF1b and HIF2a) are eYFP
negative under hypoxia, demonstrated by both microscopy (upper panel a–d) and FACS results (lower panel e and f). Equal amount of cells (5610
4)
were plated in culture dishes and microscopy and FACS analysis were performed after 2 days after siRNA transfection.
doi:10.1371/journal.pone.0027460.g003
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both cervical cancer cell lines that exhibit very distinct responses to
hypoxia. In order to understand the regulation of HIFa in these
two cervical cancer cell lines, we analyzed mRNA microarray data
previously performed in these cell lines in 2% hypoxia [38].
Interestingly, we identified hsp90 mRNA differentially expressed
between HeLa and ME180. We first validated this finding by real-
time PCR analysis and showed that ME180 has higher levels of
hsp90 both in normoxia and hypoxia (Figure 7). To determine
whether higher levels of hsp90 in ME180 could be causal for
higher HIF activity, we reduced hsp90 binding to HIF1a in
ME180 by incubating cells with 17-allylamino-demethoxygelda-
mycin (17-AAG) in 2% hypoxic conditions. 17-AAG inhibits ATP
binding to hsp90, thereby preventing the interaction of hsp90 and
its target protein [39]. Since hsp90 interaction with HIF1a is
shown to increase HIF1 stability in hypoxia [11], 17-AAG should
reduce hsp90 dependent HIF1 activity. Accordingly, 6U-HBR
ME180 incubated with 17-AAG showed lower levels of 6U-HBR
reporter activity than observed in the controls (Figure 8a).
Furthermore, the mRNA expression of HIF1a target gene CA9
was significantly reduced (Figure 8b), suggesting that HIF activity
was reduced in ME180 when hsp90 was rendered inactive. These
data support the hypothesis that the difference in hsp90 levels is
causal for the difference in HIF activity observed in the two
cervical cancer cell lines. We excluded the possibility of reduction
of HIF activities caused by general transcriptional regulation in the
cells by showing stable expression of another endogenous
housekeeping gene in both cell types (WYHAZ, Figure 8c).
Discussion
Here we create and characterize a novel HIF reporter construct,
in which eYFP expression is regulated by tandem repeats of
minimal HIF1a and HIF2a binding sites. By employing cells that
Figure 4. Sensitivity of 6U-HBR construct. a) 6U-HBR construct in A549 is activated either with ndHIF1a or ndHIF2a, but not with empty vector
construct. b–d) HIF1b siRNA alone largely reduces fluorescent signals induced by ndHIF1a/ndHF2a over-expression (ndHIFa OE) in HeLa cells,
indicating that the eYFP signals are reversible by manipulating levels of HIF factors. Both microscopy images (b) and fluorescent quantification (c and
d) are shown.
doi:10.1371/journal.pone.0027460.g004
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that cells with 6 tandem repeats as the promoter in the construct
(6U-HBR) give better signal-to-background ratio than those with 3
or 12 repeats. Also, in terms of reporter kinetics, the 6U-HBR
construct achieves a stronger signal in the process of deoxygen-
ation, while cells with 6U-destabilized-HBR construct more
accurately reflect the reduction of HIF levels in the process of
reoxygenation. Moreover, through siRNA studies against HIF1a,
HIF2a and HIF1b as well as over-expression studies of ndHIF1a
and ndHIF2a, we demonstrate that the construct is HIF specific
and is able to respond to both HIF1a and HIF2a. Utilizing 5
different cancer cell lines infected with 6U-HBR construct, we
observe that different cancer cell lines have distinct eYFP signals
under the same oxygen levels, which correlate with the total
amount of HIF1 a and HIF2 a proteins in these cell lines.
We utilized the reporter to explore difference in the hypoxic
response of HeLa and ME180 cervical cancer cell lines. We
observed that these two cancer cell lines have distinct 6U-HBR
signals which correlate with the amount of HIFa proteins in
response to the same level of hypoxia. Similarly, the different
behaviors between HeLa and ME180 under hypoxia are also
observed in angiogenic growth factor expression [40,41] as well as
in proteasome, histone deacetylase [42] and Hsp90 action [43].
Among them, Hsp90 is of particular interest. In accordance to
previous analysis [43], we show that ME180 has higher levels of
Hsp90 mRNA than HeLa both under normoxia and hypoxia.
Higher basal level of HIF cofactor Hsp90 in ME180 could
contribute to the observed higher HIF activity, since hsp90
binding to HIF has been reported to protect HIFa against VHL-
independent degradation [9,11]. Low oxygen levels inactivate
PHD/VHL dependent degradation of HIF, resulting in stabilized
and active HIF transcription factor. However, HIFa is even-
tually degraded in hypoxic conditions. This VHL-independent
degradation of HIF1a has shown to be RACK1 dependent [11].
Hsp90 competes with RACK1 binding to HIF1a, thereby
protecting HIF1a against hypoxic degradation. In present study,
we show that ME180 cells have higher levels of hsp90 and more
stable HIFa proteins compared to HeLa (Figure 6). We further
show that reduction of hsp90 in ME180 diminishes the difference
of HIF level and activity as compared to HeLa. These data suggest
that different Hsp90 levels could be causal for the different HIF
activity levels observed in the two cervical cancer cell lines under
the same level of hypoxia. It will be interesting to test in the future
whether oxygen/PDH/VHL-independent HIFa degradation is in
general the key regulator of the HIF activity differences observed
in cancer cell lines under the same level of hypoxia.
It is known that cervical cancer cells are often infected with an
oncogenic-type human papillomavirus (HPV), and HeLa is
transformed by HPV18 while ME180 by HPV68. HPV of
different types vary in the expression and regulation of the two
primary HPV oncogenes, E6 and E7 [44], that are sufficient to
alter HIF-1a level. HPV11 E6 and HPV31 E6 can stimulate HIF-
1a expression as a consequence of ubiquitin-dependent degrada-
tion of p53 [45] while HPV16 E7 can interact with a cullin-2
ubiquitin ligase complex that mediates VHL-dependent HIFa
degradation [46]. It will be interesting to reveal in the future
whether different responses to hypoxia observed in HeLa and
ME180 are associated with the type of oncogenic HPV they are
infected with.
In this study we report a novel HIF reporter construct
containing tandem repeats of minimum HIF binding sites
upstream of eYFP coding sequence. We show that the signal of
the reporter is HIF dependent and correlates with the cellular HIF
protein levels in different cell lines. By utilizing this new construct,
we find a surprising variation of HIF activity in different cancer
cell lines under the same level of hypoxia. This novel HIF reporter
Figure 5. Cancer cells with 6U-HBR show different levels of HIF activity under hypoxia. Five cancer cell lines infected with 6U-HBR
lentivirus were cultured under various degree of hypoxia, including 20%, 5%, 3%, 2%, 1% and 0.3% of O2. Their eYFP intensities were determined after
4 days in culture by FACS analysis. The degrees of hypoxia are presented as log of relative O2 level to normoxia (20% O2).
doi:10.1371/journal.pone.0027460.g005
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and therefore therapeutic capacity of potential HIF repressors in
individual cancers.
Materials and Methods
Cells, tissue culture and hypoxia induction
HeLa and ME180 (cervical carcinoma), A549 (lung carcinoma),
U251 (glioma) cells were from the American Type Culture
Collection (Rockville, MD). 786-O cells transfected with a wild-
type VHL were obtained from Dr. William G. Kaelin Jr. (Dana-
Farber Institute, Boston, MA). Cancer cells were grown in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with penicillin, streptomycin and 10% fetal bovine serum (FBS,
Invitrogen, Carlsbad, CA). Cells were passed with Trypsin/EDTA
(Invitrogen, Carlsbad, CA) when they reached 80% confluence.
Hypoxia induction
Cells were cultured in multi-gas incubators (Sanyo, San Diego,
CA). Nitrogen gas was supplied to the chambers in order to induce
a controlled reduced percentage of oxygen. For normoxia, cells
were cultured in incubators containing 5% CO2 and atmospheric
concentration of O2, approximately 20% to 21% O2. Throughout
this paper ‘‘normoxia’’ was referred as 20% O2.
Lentiviral plasmid construction
We generated HIF reporter construct with HIF1a consensus
binding site CGTG followed HIF2a site TACGTG together as
Figure 6. HIF protein levels vary in different cancer cells under 1% O2. a) HIF1a in ME180, U251, A549, HeLa and 786-O+VHL cells under 1%
O2 for 4 hours. b) Quantification for HIF1a protein shown in a). Quantification was performed on scanned film images obtained from separate
western blots. c) HIF1a levels and d) quantification in ME180, U251, A549, HeLa and 786-O+VHL cells under 1% O2 at three time points: 4 hours,
12 hours and 48 hours, compared to the levels under 20% O2 as controls.
doi:10.1371/journal.pone.0027460.g006
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tandem 12 times (12U-HBR), with 5 base pairs of nucleotides of
various combinations spacing between. Induction element CA-
CAG, a DNA element necessary for hypoxic induction, was evenly
inserted into the whole sequences three times to assist in the
induction process. The final HIF-binding sequences were directly
synthesized by Integrated DNA Technologies, Inc, Coralville,
Iowa (Figure S1). TK minimal promoter followed by 770 bps b-
globin intron sequences and eYFP was amplified from pBARL
plasmid (courtesy of Dr. Randall Moon laboratory, University of
Washington, Seattle, WA) and linked to HIF-binding sequence by
fusion PCR. The HIF-TK-eYFP sequences were further ligated
into a lentiviral plasmid pRRL-cPPT-X-PRE-SIN [47] (courtesy
of Dr. William Osborne laboratory, University of Washington,
Seattle, WA) between ClaI and XhoI sites. 6U-HBR and 3U-HBR
were constructed in the same way, except the HIF-binding
sequences only contain six binding repeats (6U-HBR) or three
repeats (3U-HBR). To build up 6U-HBR-destabilized version, the
mouse ornithine decarboxylase 422–461 domain sequences were
first amplified from Plasmid M38 TOP-dGFP (courtesy of Dr.
Randall Moon laboratory) and then inserted into 6U-HBR
construct through MluI site following the 39 of eYFP sequence.
Lentivirus production and stable transduction of cell lines
Lentiviral plasmids were transfected into FT293 cell lines
(Invitrogen, Inc, Carlsbad, CA) by calcium phosphate transfection
to produce lentiviral particles. Specifically, transferring plasmid
(12U-HBR, 6U-HBR, 3U-HBR, or 6U-HBR-destabilized con-
struct), packaging plasmid, VSVG plasmid and REV plasmid were
transfected together at 23:15:8:11.5 ratio, and 25 mg of mixed
plasmids were transfected per 150 mm plate with 1 mL of 2X
HBS and 0.1 mL 2.5 M CaCl2. After transfection, media were
changed after 24 hours and viral supernatants were harvested and
filtered after 72 hours. To obtain concentrated virus, the viral
supernatants were further centrifuged at 6100 rpm for 17 hours at
4uC. Precipitate was resuspended in 1X TBS (50 mM Tris.HCl,
pH 7.4 and 150 mM NaCl) and then stored in 280uC before use.
To transduce cell lines with virus, appropriate amount of virus
were directly added into the media with the presence of hex-
adimethrine bromide at 4 ng/ml (Polybrene, Invitrogen Inc,
Carlsbad, CA) and media was changed after 24 hours.
Fluorescence-activated cell sorting (FACS) analysis
Cells to be analyzed were trypsinized from plates, centrifuged
down and then fixed in 4% of paraformaldehyde for at least
30 minutes before the analysis. Standard settings were applied in
cell sorting with appropriate channel voltages and at least 30,000
cells were analyzed for each experiment. FITC channel was used
to detect eYFP fluorescence. FlowJo (Tree Star, Inc. Ashland, OR)
was employed to visualize data and FITC values were defined as
the geometric mean of florescence intensity of eYFP positive
population for hypoxic samples. For samples incubated in 20%
O2, the intensities were defined as the geometric mean of flore-
scence intensity of eYFP of the total population (eYFP negative).
Non-degradable HIF (ndHIF) over expression
To obtain constitutively stable expression HIFa protein, ndHIF
over-expressing plasmids (Addgene plasmid 19005 and 19006)
were used, in which two the Proline sites of HIF cDNA were
changed to Alanine as described previously [48]. Retrovirus made
from those plasmids were infected into HeLa and A549 cell lines in
the presence of hexadimethrine bromide at 4 ng/ml (Polybrene,
Invitrogen Inc. Carlsbad, CA) and media was changed after
24 hours. Over-expression of HIF1a and HIF2a was confirmed by
western blots as shown in Figure S6.
siRNA against HIF assay
siRNAs against HIF factor were gift of Dr. Zhan Zhang [38].
siRNAs were transient transfected into cells on 6-well plate with
Lipofectamine 2000 (Invitrogen Inc. Carlsbad, CA) following the
Lipofectamine 2000 instruction. Normally, ,60% reduction
of gene expression is obtained after two days (Figure S3b).
Specifically, siRNAs and Lipofectamine were transfected at
100 pmol: 2.5 ml per well. Media was changed after 24 hours
and cells were cultured under hypoxia thereafter. Cells were fixed
for FACS after 24 hours in hypoxia. In the high through-put
experiment, 6U-HBR HeLa cells stably expressing ndHIF1a/
ndHIF2a (ndHIFa OE) or empty vector (EV) were plated in 384-
well plate. HIF1b siRNA or scramble siRNA was transfected into
ndHIFa OE cells and EV cells in 384-well plate using RNAiMAX
reagent (Invitrogen Inc, Carlsbad, CA). Operetta high content
imaging system (PerkinElmer, San Jose, CA) was used for
microscopy images and fluorescence quantification.
HIF protein western blots
For Western blotting analysis, cells were washed with DPBS and
directly lysed on culture dish using homogenizing buffer consisting
of 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 15% Glycerol, 1%
Triton, 3% SDS, 25 mM b-glycerolphosphate, 50 mM NaF,
10 mM NaPyrophosphate, 0.5% Orthovanadate, 1% PMSF (all
chemicals are from Sigma-Aldrich, St. Louis, MO), 25 U
BenzonaseH Nuclease (EMD Chemicals, Gibbstown, NJ) and
protease inhibitor cocktail (Complete Mini, Roche Applied
Science, Germany). The protein concentration of each sample
was determined by BCA protein assay system (Thermo Scientific,
Rockford, IL). 20 mg of protein extracts were loaded, separated by
7.5% SDS-PAGE, and transferred to polyvinylidene difluoride
membranes (Hybond-N+, Amersham Pharmacia Biotech, Buck-
inghamshire, England). Membranes were blocked with 5% non-
fat dry milk for at least 60 minutes at room temperature, and
Figure 7. Hsp90 mRNA levels are different in ME180 and HeLa
both under hypoxia and normoxia. Cells were either incubated
under 1% hypoxia or 20% normoxia for 48 hours before quantification
the hsp90 mRNA level by real-time PCR. The error bars are presented as
sample error of the mean (SEM) from three independent biological
experiments.
doi:10.1371/journal.pone.0027460.g007
Assessment of HIF Levels Using a Novel Reporter
PLoS ONE | www.plosone.org 9 November 2011 | Volume 6 | Issue 11 | e27460incubated overnight at 4uC with HIF1a antibody (BD biosciences,
San Jose, CA) diluted at 1:2000, or HIF2a antibody (Abcam,
Cambridge, MA) diluted at 1:1000 (or HIF2a antibody from
Novus Biologicals diluted at 1:5000). Finally, after blots had been
incubated for 1 hour with horseradish peroxidase-conjugated
secondary antibodies, they were visualized by enhanced chemilu-
minescence (Millipore Corp, Billerica, MA). Protein expression
levels in the gel were quantified by densitometry implemented in
Image-J (National Institutes of Health, Bethesda http://rsb.info.
nih.gov/ij/, 1997–2009).
mRNA quantification among different cell lines
RNA was extracted from cells adherent on plates using Trizol
reagent (Invitrogen Inc. Carlsbad, CA) and cDNA was synthesized
with Omniscript RT kit (Qiagen Inc. Valencia, CA). To determine
the normalization factor, geNorm algorithm was used to seek
appropriateendogenoushousekeepinggenesforcomparison among
different cell lines [49]. HPRT1 and YWHAZ were chose as the
endogenous control genes for normalization. mRNA level of
HIF1a, HIF2a, Hsp90 and endogenous control genes were quan-
tified in triplicates of 20 ml of PCR reactions using SyberGreen
system (Applied Biosystems, Foster City, CA), each with 25 ng
cDNA. All of the reactions were performed in 7300 real time PCR
system (Applied Biosystems, Foster City, CA) using default settings.
Thefollowingprimerswereused inthe quantification:HIF1a_F:59-
TCCATGTGACCATGAGGAAA-39 and HIF1a_R: 59-CCAAG-
CAGGTCATAGGTGGT -39; HIF2a_F: 59-CCACCAGCTT-
CACTCTCTCC-39 and HIF2a_R: 59-TCAGAAAAGGCCAC-
TGCTT-39; hsp90_F: 59-TCTGGAAGATCCCCAGACAC-39,
hsp90_R: 59- AGTCATCCCTCAGCCAGAGA-39.
Figure 8. 17-AAG reduces the difference in HIF levels and its transcriptional activity between ME180 and HeLa. Results of three
independent experiments are summarized and the error bars are presented as sample error of the mean (SEM). a) Fluorescence intensities of HeLa in
DMSO, ME180 in DMSO and ME180 in 100 nM 17-AAG in 2% hypoxia are normalized to that in 20% normoxia. b) The fold changes of CA9 mRNA
levels normalized to 20% normoxia in those cells suggest that the difference, in terms of HIF activity, is reduced in the presence of 17-AAG. c) The
stable expression of another housekeeping gene, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
(YWHAZ), demonstrates the generally normal transcriptional activities in those cells treated either with DMSO or 17-AAG.
doi:10.1371/journal.pone.0027460.g008
Assessment of HIF Levels Using a Novel Reporter
PLoS ONE | www.plosone.org 10 November 2011 | Volume 6 | Issue 11 | e27460Knockdown of hsp90 through 17-AAG
Cells were incubated in 2% hypoxia with 100 nM 17-AAG in
media for 24 hours and then replaced by fresh media. Cells were
fixed for FACS or harvested for mRNA quantification after
48 hours in hypoxia.
Supporting Information
Figure S1 Promoter sequence of 12U-HBR construct.
The minimal TK promoter is not shown.
(TIF)
Figure S2 6U-HBR HeLa cells response to hypoxia as
reflected by the reporter construct. a) 6U-HBR HeLa cells
turn eYFP on in 2% but not in 20% oxygen. Equal amount of cells
(5610
4) were plated in both culture dishes and FACS analysis
were performed after 2 days. The percentages of eYFP positive
cells under these conditions are shown. b) The patterns of 6U-
HBR HeLa cells in response to different levels of hypoxia. The
percentages of eYFP positive cells and the mean intensity of each
sample were shown.
(TIF)
Figure S3 6U-HBR construct is HIF-dependent. a)
siRNAs assays against various combinations of HIFs demonstrate
that the construct is HIF-dependent. HeLa cells were incubated in
2% O2 for one day after siRNA transfection; b) Validation is
shown for knockdown experiments of HIF1b expression by HIF1b
siRNAs. Mean and error bars are from three biological repeats.
(TIF)
Figure S4 HIFa mRNA levels in ME180, U251 and HeLa
cancer cell lines. Delta Ct is calculated directly from Ct values
of endogenous genes (HPRT1 and YWHAZ) minus that of HIF1a
or HIF2a.
(TIF)
Figure S5 HIF2a protein levels under 1% O2 in five cell
lines. a) HIF2a in ME180, U251, A549, HeLa and 786-O+VHL
cells under 1% O2 for 4 hours. b) HIF2a levels in ME180, U251,
A549, HeLa and 786-O+VHL cells under 1% O2 at three time
points: 4 hours, 12 hours and 48 hours, compared to the levels
under 20% O2 as controls. HIF2a antibody (Novus Biologi-
cals,CO, NB100-122) was used.
(TIF)
Figure S6 Over-expression of HIF1a and HIF2a by
retroviral infection was confirmed in western blots.
HIF2a antibody (Abcam, Cambridge, MA, ab20654) was used.
(TIF)
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